Shi-bing Li

Guangzhou, 510655, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Platelet Indices and ApoA1 as Predictive Markers in Neoadjuvant Immunochemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Retrospective Study.

Platelet Indices and ApoA1 as Predictive Markers in Neoadjuvant Immunochemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Retrospective Study.

Journal: Journal of inflammation research

Published: October 02, 2025

OASL enhances mRNA translation and reprograms lipid metabolism to promote cancer progression.

OASL enhances mRNA translation and reprograms lipid metabolism to promote cancer progression.

Journal: Cell reports

Published: December 04, 2024

PXDN as a pan-cancer biomarker and promotes tumor progress via immune inhibition in nasopharyngeal carcinoma.

PXDN as a pan-cancer biomarker and promotes tumor progress via immune inhibition in nasopharyngeal carcinoma.

Journal: Frontiers in oncology

Published: July 11, 2024

Autocrine INSL5 promotes tumor progression and glycolysis via activation of STAT5 signaling.

Autocrine INSL5 promotes tumor progression and glycolysis via activation of STAT5 signaling.

Journal: EMBO molecular medicine

Published: January 18, 2020

Corrigendum to "Identification of a sodium pump Na+/K+ ATPase α1-targeted peptide for PET imaging of breast cancer" [Journal of Controlled Release 281C (2018) 178-188].

Corrigendum to "Identification of a sodium pump Na+/K+ ATPase α1-targeted peptide for PET imaging of breast cancer" [Journal of Controlled Release 281C (2018) 178-188].

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: August 27, 2019

Correction to: Elevated expression of CST1 promotes breast cancer progression and predicts a poor prognosis.

Correction to: Elevated expression of CST1 promotes breast cancer progression and predicts a poor prognosis.

Journal: Journal of molecular medicine (Berlin, Germany)

Published: June 17, 2019

Author Correction: Ephrin receptor A2 is an epithelial cell receptor for Epstein-Barr virus entry.

Author Correction: Ephrin receptor A2 is an epithelial cell receptor for Epstein-Barr virus entry.

Journal: Nature microbiology

Published: April 22, 2018

Plasma Macrophage Migration Inhibitory Factor and CCL3 as Potential Biomarkers for Distinguishing Patients with Nasopharyngeal Carcinoma from High-Risk Individuals Who Have Positive Epstein-Barr Virus Capsid Antigen-Specific IgA.

Plasma Macrophage Migration Inhibitory Factor and CCL3 as Potential Biomarkers for Distinguishing Patients with Nasopharyngeal Carcinoma from High-Risk Individuals Who Have Positive Epstein-Barr Virus Capsid Antigen-Specific IgA.

Journal: Cancer research and treatment

Published: January 29, 2018

Identification of a sodium pump Na+/K+ ATPase α1-targeted peptide for PET imaging of breast cancer.

Identification of a sodium pump Na+/K+ ATPase α1-targeted peptide for PET imaging of breast cancer.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: December 05, 2017

CRLF1 promotes malignant phenotypes of papillary thyroid carcinoma by activating the MAPK/ERK and PI3K/AKT pathways.

CRLF1 promotes malignant phenotypes of papillary thyroid carcinoma by activating the MAPK/ERK and PI3K/AKT pathways.

Journal: Cell death & disease

Published: November 04, 2017

Ephrin receptor A2 is an epithelial cell receptor for Epstein-Barr virus entry.

Ephrin receptor A2 is an epithelial cell receptor for Epstein-Barr virus entry.

Journal: Nature microbiology

Published: August 28, 2017

Elevated expression of CST1 promotes breast cancer progression and predicts a poor prognosis.

Elevated expression of CST1 promotes breast cancer progression and predicts a poor prognosis.

Journal: Journal of molecular medicine (Berlin, Germany)

Published: December 16, 2016

Showing 1-12 of 12

Last Updated: 09/26/2026